3 completed, 2 terminated, 1 recruiting, 1 unknown. 5 Phase 2, 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Terminated 2, Recruiting 1 |
| Early Phase 1 | 1 | Unknown 1 |
| Not applicable | 1 | Completed 1 |
Follow cannabidivarin: new trials by email Literature Review of cannabidivarin trials Research Report on cannabidivarin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series Hemp Oil - Androgenetic Alopecia | Early Phase 1 | Unknown | Gregory L Smith, MD, MPH | 40 | 2021-04-05 | 2021-04-15 |
| CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS) CBDV Compound, Placebo - Prader-Willi Syndrome | Phase 2 | Terminated | Eric Hollander | 6 | 2020-11-23 | 2026-05-07 |
| Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder GWP42006 - Autism Spectrum Disorder | Phase 2 | Terminated | Jazz Pharmaceuticals | 1 | 2020-01-07 | 2022-09-02 |
| Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) Cannabidivarin, Matched Placebo - Autism Spectrum Disorder | Phase 2 | Recruiting | Montefiore Medical Center | 100 | 2019-04-12 | 2025-10-22 |
| Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder PLC, CBD, CBDV - Autism Spectrum Disorder | Not applicable | Completed | King's College London | 38 | 2016-08-22 | 2024-03-05 |
| A Study of GWP42006 in People With Focal Seizures - Part B GWP42006, Placebo Control - Epilepsy, Focal Seizures | Phase 2 | Completed | Jazz Pharmaceuticals | 162 | 2016-03-01 | 2022-12-20 |
| A Study of GWP42006 in People With Focal Seizures - Part A GWP42006, Placebo - Epilepsy, Focal Seizures | Phase 2 | Completed | Jazz Pharmaceuticals | 32 | 2015-03-01 | 2022-12-20 |
Autism Spectrum Disorder (3) · Epilepsy (2) · Seizures (2) · Alopecia (1) · Autistic Disorder (1) · Prader-Willi Syndrome (1)
Jazz Pharmaceuticals (3) · Eric Hollander (1) · Gregory L Smith, MD, MPH (1) · King's College London (1) · Montefiore Medical Center (1)
United States (4) · United Kingdom (3) · Czechia (2) · Spain (2) · Hungary (1) · Italy (1) · Poland (1)
Eric Hollander, MD (2) · Grainne McAlonan, PhD (1) · Gregory L Smith, MD (1)
PMID 33998885, PMID 34210360, PMID 40656115
2014 (2)